SQI Diagnostics Inc.
SQIDF · OTC
9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Revenue | $8 | $1 | $1 | $2 |
| % Growth | 783.5% | -10.4% | -45.9% | – |
| Cost of Goods Sold | $5 | $0 | $0 | $1 |
| Gross Profit | $3 | $1 | $1 | $1 |
| % Margin | 38.3% | 83.6% | 77.3% | 67.8% |
| R&D Expenses | $7 | $8 | $4 | $5 |
| G&A Expenses | $6 | $3 | $3 | $2 |
| SG&A Expenses | $7 | $3 | $4 | $3 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $17 | $11 | $9 | $9 |
| Operating Income | -$20 | -$10 | -$8 | -$7 |
| % Margin | -241.4% | -1,094.8% | -771.5% | -389.5% |
| Other Income/Exp. Net | $1 | -$1 | -$1 | -$0 |
| Pre-Tax Income | -$19 | -$11 | -$9 | -$8 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$19 | -$11 | -$9 | -$8 |
| % Margin | -228.6% | -1,151.3% | -837.8% | -424.2% |
| EPS | -0.048 | -0.031 | -0.032 | -0.045 |
| % Growth | -52.2% | 2.8% | 28.7% | – |
| EPS Diluted | -0.048 | -0.031 | -0.032 | -0.045 |
| Weighted Avg Shares Out | 390 | 338 | 267 | 178 |
| Weighted Avg Shares Out Dil | 390 | 338 | 267 | 178 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3 | $1 | $1 | $1 |
| Depreciation & Amortization | $4 | $1 | $1 | $1 |
| EBITDA | -$10 | -$9 | -$7 | -$7 |
| % Margin | -124% | -1,012.6% | -693.3% | -363% |